This paper reflects on two decades of building NLP resources and research infrastructure for Arabic, an historically underserved language. The first decade focused on foundational linguistic infrastructure, while the second shifted towards computational social science and socially oriented applications. The authors highlight three lessons: dataset building is a social process, communities often matter more than shared tasks, and computational social science exposes challenges beyond traditional NLP training. Why it matters: The paper argues that the most difficult problems in developing NLP for underserved communities are social, institutional, and epistemic, offering critical insights for future research directions in Arabic AI.
MBZUAI and Quris-AI have partnered to launch a Bio-AI center in Abu Dhabi during Abu Dhabi Sustainability Week. The center will focus on developing personalized medications tailored to the MENA region's diverse populations, leveraging Quris-AI's 'patient-on-a-chip' technology and MBZUAI's AI expertise. Quris-AI is establishing a UAE subsidiary, Quris-UAE, in Abu Dhabi as part of this collaboration. Why it matters: This initiative positions Abu Dhabi as a hub for Bio-AI research and personalized medicine, potentially accelerating drug development and reducing clinical trial failures in the region.
Meta's Muse AI, a generative AI tool, reportedly faced significant public criticism and a subsequent shutdown due to its generation of inappropriate and biased content. This incident highlights a recurring pattern of major technology companies launching AI products prematurely without sufficient ethical safeguards or rigorous testing. The article critiques Big Tech for prioritizing speed and market dominance over responsible AI development and societal impact. Why it matters: This ongoing trend of high-profile AI failures from global tech giants provides critical lessons for emerging AI ecosystems in the Middle East regarding the importance of robust ethical frameworks and thorough product validation.
Hattan Ahmed, Head of the KAUST Entrepreneurship Center, emphasizes the importance of community for entrepreneurial success, noting that even visionary entrepreneurs rely on support networks. A supportive community can be the difference between success and failure for startups. KAUST aims to foster such an environment to attract talent, investment, and encourage future entrepreneurs in Saudi Arabia. Why it matters: This highlights the strategic focus on community building to accelerate startup growth and innovation within Saudi Arabia's evolving entrepreneurial ecosystem.
Ahmed Al Saleh, a 2017 KAUST material science and engineering graduate, is now a business development manager at Thermo Fisher Scientific. He is the first Saudi to work for the company, representing them in Saudi Arabia from their KAUST campus office. Al Saleh advises KAUST students to experiment and develop their social skills, embracing failure as part of the learning process. Why it matters: This highlights KAUST's role in developing local talent for key science and technology sectors in Saudi Arabia.
Dr. Samuel West, curator of the Museum of Failure, delivered a keynote lecture at KAUST on learning from innovation failure. He emphasized accepting failure, encouraging innovation, and framing work as learning problems. West used case studies like TwitterPeek and the Vasa warship to illustrate learning from past mistakes. Why it matters: This promotes a culture of experimentation and resilience, crucial for advancing AI and technology innovation in Saudi Arabia.
MBZUAI graduate Svetlana Maslenkova worked with Assistant Professor Mohammad Yaqub on a project focused on the earlier detection of kidney failure using tabular data. Maslenkova's master's thesis involved predicting Acute Kidney Injury (AKI) using Electronic Health Records (EHR), specifically the MIMIC-IV v2.0 database. She found that patient weight distribution was a factor in the severity of kidney failure. Why it matters: This research highlights the potential of AI and machine learning to improve healthcare outcomes through the analysis of often-overlooked tabular data in electronic health records.
MBZUAI's Kun Zhang is applying causal machine learning to improve drug development and precision medicine, focusing on answering 'why' questions. Traditional drug development is costly (est. $2B) due to extensive studies needed to determine drug toxicity and efficacy. Zhang is combining causal ML with organs-on-chips technology to improve pre-clinical drug testing, aiming to reduce the failure rate of drugs in human trials. Why it matters: By improving the accuracy of pre-clinical drug testing, this research could significantly reduce the cost and time required to bring new medicines to market in the region and worldwide.